Project description
A new biocompatible polymer for microfluidics
The market for microfluidic devices all over the world was worth USD 3.6 billion in 2017, and it is poised for a double digit growth by 2022. This growth is likely to be driven by the rising demand for point-of-care devices and polymerase chain reaction chips. France-based company Eden Tech aspires to implement elements of the 'Factory of the Future', counting on proprietary advanced materials for microfluidics, microfabrication machines and design services for end users. The company has patented its first biocompatible polymer, Flexdym, which is particularly well-suited for microfluidics in biological applications. The EU-funded FLEXDYM project is supporting this unique technology, which could boost microfluidics device production, helping bridge the existing gap between academia and industry.
Objective
Eden Microfluidics specializes in advanced materials and microfabrication solutions for microfluidics, and uses its expertise to develop innovative solutions for MedTech, CleanTech, Cosmetics and Pharma.
Eden’s initial market, microfluidic systems, is emerging from R&D labs into commercialisation. In the last few years, key applications benefited from microfluidic breakthroughs, accelerating growth. These applications (PCR chips, Point of Care testing, …) are driving a dynamic microfluidic devices market, showing a 18% CAGR2017-2022, currently at $2.5B in 2017 and expected to reach almost US$6B in 2022. Yet, microfluidics is still very dependent on prototyping materials and methods, which can't be commercialized easily.
Eden Microfluidics has patented the first polymer for microfluidics, the only one that permits easy transition from prototyping to commercialization. With this polymer, and its microfabrication companion, Eden is poised to engage with all customers: prototypers, manufacturers and providers.
The vision of Eden Microfluidics is to become the leader in microfluidic systems and to do so, it envisions a « factory of the future » with proprietary advanced materials for microfluidics, microfabrication machines and design services for its end-users. With it, Eden will design, create and produce microfluidic systems for Market 2 (MedTech), Market 3 (CleanTech), and even beyond.
With the SME instrument, Eden Microfluidics will establish additional markets that could be reached with new formulation of advanced materials, variant of its first product: Flexdym.
Fields of science
- natural sciencesphysical sciencesclassical mechanicsfluid mechanicsmicrofluidics
- natural scienceschemical sciencespolymer sciences
- natural sciencesphysical scienceselectromagnetism and electronicsmicroelectronics
- engineering and technologyenvironmental engineeringcarbon capture engineering
- engineering and technologyenvironmental engineeringenergy and fuelsfuel cells
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
75015 Paris
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.